Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(23):1733; doi:10.1093/jnci/95.23.1733-b
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content

© 2003 Oxford University Press

IN THIS ISSUE

The first 10% of the full text of this article appears below.

PSA Screening in Elderly Men

Despite the overall controversy regarding prostate-specific antigen (PSA) screening for prostate cancer, there has been general agreement that elderly men (i.e., those aged 75 years or older) should not be screened. Lu-Yao et al. (p. 1792) looked at PSA screening in the context of cancer screening in general by examining the responses of participants in the 2000 National Health Interview Survey. They found that the rate of PSA screening among elderly men was 32.5%, which was greater than that of fecal occult blood screening among elderly men (22.8%), but comparable with that of annual Pap smear screening . . . [Full Text of this Article]

Hot Flashes, SSRIs, and Tamoxifen

Calcium, Vitamin D, and Colorectal Cancer

Human Papillomavirus and Oral Cancer

NSAIDs and Gastric Cancer

Cancer Incidence Among Type 1 Diabetes Patients